A new study shows that while decentralized clinical trials (DCTs) are making research more accessible, they also bring ...

Early human factors testing can reveal critical blind spots, cut medical device development costs and steer overall product ...

Results show biopsy-proven resolution of BK polyomavirus nephropathy in kidney transplant recipients No safety or ...

The first patient has been treated with InterVene’s Recana thrombectomy system for restoring patency (blood flow) in chronically obstructed deep veins and venous stents.

Arquitos Capital Management gained 13.1% in Q2 2025. Learn how they turned market uncertainty into opportunity with Liquidia ...

Remote and technology-driven approach to studies makes it harder to build relationships, establish trust, understand what ...

The selection of BD LibertasTM Wearable Injector for this pharma-sponsored trial follows successful outcomes from more than 50 BD-conducted pre-clini ...

Sona CEO, David Regan, commented, "Cases of melanoma have tripled in 30 years in Canada where over 1,300 people die every year from this disease. For that reason, we are excited to be laying the ...

The biologic and biosimilar era has brought about more clinical trials in rheumatology than ever before, and with increasing ...

Nanochon gets Health Canada approval for first in human investigation to assess safety and performance of its Chondrograft system: Washington Saturday, July 19, 2025, 16:00 Hrs [I ...

Industry experts have provided insight into how oncology clinical trials can be designed for success from the outset and rendered as patient-centric as possible.